Rag2Mol: structure-based drug design based on retrieval augmented generation
Briefings in Bioinformatics · 01.05.2025 · 26 (3)
DOI: 10.1093/bib/bbaf265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 12.06.2025. Verfasst von Peidong Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Technology, Tsinghua University, Haidian District, Beijing 100084, China. Hauptthemen laut MEDLINE: Drug Design. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Guoqiang Institute of Tsinghua University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Artificial intelligence (AI) has brought tremendous progress to drug discovery, yet identifying hit and lead compounds with optimal physicochemical and pharmacological properties remains a significant challenge. Structure-based drug design (SBDD) has emerged as a promising paradigm, but the inherent data biases and ignorance of synthetic accessibility render SBDD models disconnected from practical drug discovery. In this work, we explore two methodologies, Rag2Mol-G and Rag2Mol-R, both based on retrieval-augmented generation to design small molecules to fit a 3D pocket. These two methods involve searching for similar small molecules that are purchasable in the database based on the generated ones or creating new molecules from those in the database that can fit into a 3D pocket. Experimental results demonstrate that Rag2Mol methods consistently produce drug candidates with superior binding affinities and drug-likeness. We find that Rag2Mol-R provides a broader coverage of the chemical landscapes and more precise targeting capability than advanced virtual screening models. Notably, both workflows identified promising inhibitors for the challenging target protein tyrosine phosphatases PTPN2, which was used to be considered undruggable and still lacks inhibitors that have completed full clinical trials. Our highly extensible framework can integrate diverse SBDD methods, marking a significant advancement in AI-driven SBDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Computer Science and Technology, Tsinghua University, Haidian District, Beijing 100084, China.
- Institute of Artificial Intelligence, Tsinghua University, Haidian District, Beijing 100084, China.
- Institute for Artificial Intelligence, Peking University, Haidian District, Beijing 100084, China.
- School of Intelligence Science and Technology, Peking University, Haidian District, Beijing 100084, China.
- Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Taijiang District, Fuzhou 350004, China.
- Department of Electronic Engineering, Tsinghua University, Haidian District, Beijing 100084, China.
ORCID-Profile: Peidong Zhang
Förderung
- National Key Research and Development Program of China
- Guoqiang Institute of Tsinghua University
- National Natural Science Foundation of China
Zitieren
APA
Zhang, P., Peng, X., Han, R., Chen, T., & Ma, J. (2025). Rag2Mol: structure-based drug design based on retrieval augmented generation. Briefings in Bioinformatics, 26(3). https://doi.org/10.1093/bib/bbaf265
Vancouver
Zhang P, Peng X, Han R, Chen T, Ma J. Rag2Mol: structure-based drug design based on retrieval augmented generation. Briefings in Bioinformatics. 2025;26(3). doi:10.1093/bib/bbaf265
BibTeX
@article{Zhang2025,
author = {Zhang, Peidong and Peng, Xingang and Han, Rong and Chen, Ting and Ma, Jianzhu},
title = {Rag2Mol: structure-based drug design based on retrieval augmented generation},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {3},
doi = {10.1093/bib/bbaf265}
}
EUVIMED